Imiglucerase in the treatment of Gaucher disease: a history and perspective
Patrick B Deegan, Timothy M CoxDepartment of Medicine, University of Cambridge, Lysosomal Disorders Unit, Addenbrooke's NHS Foundation Hospitals Trust, Cambridge, UKAbstract: The scientific and therapeutic development of imiglucerase (Cerezyme®) by the Genzyme Corporation is...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-04-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/imiglucerase-in-the-treatment-of-gaucher-disease-a-history-and-perspec-a9729 |